[go: up one dir, main page]

IS2377B - Fæðubótarefni til inngjafar í garnir sem næring utan meltingarvegar eða næring að hluta til um garnir/munn fyrir alvarlega veika sjúklinga, langveikasjúklinga og vannært fólk - Google Patents

Fæðubótarefni til inngjafar í garnir sem næring utan meltingarvegar eða næring að hluta til um garnir/munn fyrir alvarlega veika sjúklinga, langveikasjúklinga og vannært fólk

Info

Publication number
IS2377B
IS2377B IS6815A IS6815A IS2377B IS 2377 B IS2377 B IS 2377B IS 6815 A IS6815 A IS 6815A IS 6815 A IS6815 A IS 6815A IS 2377 B IS2377 B IS 2377B
Authority
IS
Iceland
Prior art keywords
intestinal
patients
supplements
gastrointestinal
administration
Prior art date
Application number
IS6815A
Other languages
English (en)
Other versions
IS6815A (is
Inventor
Kessler Barbara
Riedel Angelika
Suchner Ulrich
Original Assignee
Fresenius Kabi Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fresenius Kabi Deutschland Gmbh filed Critical Fresenius Kabi Deutschland Gmbh
Publication of IS6815A publication Critical patent/IS6815A/is
Publication of IS2377B publication Critical patent/IS2377B/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0029—Parenteral nutrition; Parenteral nutrition compositions as drug carriers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/13—Nucleic acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IS6815A 2000-11-17 2003-05-14 Fæðubótarefni til inngjafar í garnir sem næring utan meltingarvegar eða næring að hluta til um garnir/munn fyrir alvarlega veika sjúklinga, langveikasjúklinga og vannært fólk IS2377B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10057290A DE10057290B4 (de) 2000-11-17 2000-11-17 Enteral zu verabreichendes Supplement zur parenteralen Ernährung oder partiellen enteralen/oralen Ernährung bei kritisch Kranken, chronisch Kranken und Mangelernährten
PCT/EP2001/013163 WO2002039978A1 (de) 2000-11-17 2001-11-14 Enteral zu verabreichendes supplement zur parenteralen ernährung oder partiellen enteralen/oralen ernährung bei kritisch kranken, chronisch kranken und mangelernährten

Publications (2)

Publication Number Publication Date
IS6815A IS6815A (is) 2003-05-14
IS2377B true IS2377B (is) 2008-07-15

Family

ID=7663817

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6815A IS2377B (is) 2000-11-17 2003-05-14 Fæðubótarefni til inngjafar í garnir sem næring utan meltingarvegar eða næring að hluta til um garnir/munn fyrir alvarlega veika sjúklinga, langveikasjúklinga og vannært fólk

Country Status (28)

Country Link
US (1) US7947303B2 (is)
EP (1) EP1337236B1 (is)
JP (1) JP2004513912A (is)
KR (2) KR20080069280A (is)
CN (1) CN1477950A (is)
AT (1) ATE272390T1 (is)
AU (2) AU2484802A (is)
BR (1) BRPI0115451B1 (is)
CA (1) CA2429270C (is)
CZ (1) CZ300129B6 (is)
DE (2) DE10057290B4 (is)
DK (1) DK1337236T3 (is)
EE (1) EE05209B1 (is)
ES (1) ES2223015T3 (is)
HR (1) HRP20030395B1 (is)
HU (1) HU228351B1 (is)
IL (2) IL155840A0 (is)
IS (1) IS2377B (is)
MX (1) MXPA03004348A (is)
NO (1) NO333003B1 (is)
NZ (1) NZ525812A (is)
PL (1) PL202031B1 (is)
PT (1) PT1337236E (is)
RU (1) RU2295952C2 (is)
SI (1) SI1337236T1 (is)
SK (1) SK286199B6 (is)
WO (1) WO2002039978A1 (is)
ZA (1) ZA200303722B (is)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10254584A1 (de) * 2002-11-22 2004-06-09 HORST HEIRLER PROJEKTE für Ernährung, Medizin, Ökologie Verwendung von mittelkettigen Triglyceriden (MCT) zur ernährungsphysiologischen Optimierung des Fettsäurenspektrums in einem diätetischen Lebensmittel für Diabetiker
WO2005023274A1 (en) * 2003-09-05 2005-03-17 Yissum Research Development Company Of The Hebrew University Of Jerusalem Treatment and prevention of inflammatory disease and mitochondrial dysfunction with high dose selenium
JP2007505899A (ja) * 2003-09-19 2007-03-15 エヌ．ブイ．・ヌートリシア 多臓器機能不全を予防するための方法及び組成物
DE10349585A1 (de) * 2003-10-24 2005-06-16 Biosyn Arzneimittel Gmbh Spurenelementzusammensetzung für die Ernährung
DE202004015931U1 (de) * 2004-10-13 2005-01-05 Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh Omega-3-Fettsäuren und Omega-6-Fettsäuren enthaltende Zusammensetzung
US20050148669A1 (en) * 2004-10-21 2005-07-07 Daniel Amato Amino acid esters as nutrient supplements and methods of use
RU2433819C2 (ru) * 2004-11-09 2011-11-20 Хилл'С Пет Ньютришн, Инк. Применение антиоксидантов для модуляции генов
CN101084003A (zh) * 2004-12-21 2007-12-05 重症救护联络公司 治疗性营养组合物或联合药物及其使用方法
ES2488128T5 (es) 2005-04-27 2022-11-15 Nutricia Nv Nutrición con lípidos y sacáridos no digeribles
EP1719543A1 (en) * 2005-05-04 2006-11-08 Asan Labs., Ltd. Use of histone deacetylase inhibitors for the treatment of gastrointestinal distress
WO2006127695A2 (en) * 2005-05-23 2006-11-30 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Ascorbic acid conjugates
MX2008002701A (es) 2005-08-26 2008-03-18 Nestec Sa Nutricion para pacientes obesos.
DE102005046237A1 (de) * 2005-09-28 2007-04-05 Südzucker Aktiengesellschaft Mannheim/Ochsenfurt Buttersäureester von Kohlenhydraten und Kohlenhydratpolyolen
CN101309678B (zh) * 2005-11-15 2011-04-20 安特瑞斯公司 用于与软骨损伤有关的应用的药物
CN101365350A (zh) * 2006-01-09 2009-02-11 雀巢技术公司 应激患者的治疗
EP2032170B1 (en) * 2006-06-14 2012-11-28 N.V. Nutricia Anti-inflammatory composition comprising glycine and lactoferrin and the use thereof
MY148671A (en) * 2006-10-19 2013-05-31 Nestec Sa Long-term enteral feed for maintenance
KR100774816B1 (ko) * 2006-11-21 2007-11-07 동부일렉트로닉스 주식회사 반도체 소자의 ｍｉｍ 커패시터 제조 방법 및 구조
ATE536105T1 (de) * 2007-09-17 2011-12-15 Nutricia Nv Ernährungsformulierung mit hohem energetischen gehalt
EP2205235A4 (en) * 2007-10-14 2010-11-17 Univ Florida PREPARATION TO IMPROVE GASTROINTESTINAL FUNCTION
RU2354380C1 (ru) * 2007-11-16 2009-05-10 Государственное образовательное учреждение высшего профессионального образования "Омская государственная медицинская академия Федерального агентства по здравоохранению и социальному развитию" Росздрава" Способ медикаментозной коррекции вазомоторной функции эндотелия у детей с сахарным диабетом 1 типа, не имеющих микроангиопатий
RU2394583C1 (ru) * 2008-12-01 2010-07-20 Марк Абович Малков Средство для профилактики обменных нарушений
IT1396935B1 (it) 2009-11-26 2012-12-20 Solartium Entpr Ltd Uso di una combinazione per il trattamento delle mucositi indotte da radiazioni o da chemioterapici
JP2013529193A (ja) * 2010-04-26 2013-07-18 ネステク ソシエテ アノニム 非経口栄養から経腸栄養へ離脱させるための栄養組成物及び方法
BR112013025047A2 (pt) * 2011-03-31 2017-02-14 Nestec Sa composições nutricionais para aumentar os níveis de arginina e métodos para usar as mesmas
WO2012141316A1 (ja) 2011-04-13 2012-10-18 味の素株式会社 栄養組成物
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
EP2580967A1 (en) * 2011-10-11 2013-04-17 Nestec S.A. Accelerating muscle recovery after immobilization-induced muscle atrophy
US9849144B2 (en) 2013-09-16 2017-12-26 Healios Oncology Nutrition, LLC Glutamine and trehalose compositions
KR101572606B1 (ko) * 2014-11-24 2015-11-27 강원대학교산학협력단 Sfrp5 유래의 펩타이드 및 이를 포함하는 피부 미백용 화장료 조성물
CA2988563A1 (en) 2015-06-10 2016-12-15 Ajinomoto Co., Inc. Ameliorating agent for exercise-induced gastrointestinal disorders
ES2638195B1 (es) * 2016-04-18 2018-08-02 Bioiberica, S.A. Composiciones para la piel
CN110785815B (zh) 2017-05-09 2023-06-27 巴克斯特国际公司 胃肠外营养诊断系统、设备和方法
CN108208177A (zh) * 2017-11-28 2018-06-29 上海交通大学医学院附属新华医院 含丁酸类化合物的组合物及其应用
PL423673A1 (pl) * 2017-12-01 2019-06-03 Lewandowska Agata Kompozycja do podawania doustnego, zastosowanie kompozycji w zapobieganiu i leczeniu mucositis oraz sposób leczenia mucositis
CN115003172A (zh) * 2020-02-12 2022-09-02 帝斯曼知识产权资产管理有限公司 抗氧化剂至肠道的直接递送
WO2021191469A1 (en) * 2020-03-27 2021-09-30 Basf Se Composition for the treatment of gastro-intestinal dysfunction and/or associated morbidities thereto
US11666548B2 (en) * 2020-06-05 2023-06-06 Baxter International Inc. Parenteral nutrition formulation
US20220160669A1 (en) 2020-11-24 2022-05-26 Baxter International Inc. Parenteral nutrition formulation
DE202021102589U1 (de) 2020-12-15 2021-05-28 Marco Lautenschläger Verzehrfertiges, abgefülltes Getränk auf Basis eines natürlichen Mineralwassers
US20250195547A1 (en) * 2022-04-19 2025-06-19 Vanderbilt University Compositions and methods of treatment for congenital diarrheal disorder
WO2023215458A1 (en) * 2022-05-06 2023-11-09 Ageless Sciences, Inc. Compositions and methods for slowing down aging and extending lifespan
CN116920075B (zh) * 2023-09-15 2024-01-02 潍坊市人民医院(潍坊市公共卫生临床中心) 一种肠内营养液及其制备方法
CN120419671B (zh) * 2025-06-26 2025-10-10 成都桥然生物科技有限公司 一种儿童促生长双组分复合物配方及其制备方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3698912A (en) * 1969-07-01 1972-10-17 Morton Norwich Products Inc Process for making nutrient composition
DE3135849A1 (de) * 1981-09-10 1983-03-17 Dr. Schumacher GmbH & Co KG, 4600 Dortmund Beschichtungsstoff fuer korrosionsschutzzwecke
US4446389A (en) * 1982-03-15 1984-05-01 Ampex Corporation Quadrature tach decoder circuit
CA1285491C (en) * 1985-09-12 1991-07-02 Robert J. Smith Method of treating catabolic dysfunction
ES2007350A6 (es) * 1987-05-29 1989-06-16 Ganadera Union Ind Agro Productos alimenticios enriquecidos con nucleosidos yno nucleotidos para la nutricion infantil y de adultos, y procedimiento para su preparacion.
IL94549A (en) * 1989-06-02 1996-08-04 Brigham & Womens Hospital A pharmaceutical preparation containing glutamine
AU645070B2 (en) * 1990-04-10 1994-01-06 Nb International Technologies Use of short chain fatty acid containing lipids to maintain gastrointestinal integrity and function in patients DO NOT SEAL - SEE LETTER DATED 22.03.94
SE9002732D0 (sv) * 1990-08-24 1990-08-24 Kabivitrum Ab Product containing growth factor
JP2524551B2 (ja) * 1992-02-28 1996-08-14 雪印乳業株式会社 グルタミン含量の高いペプチド組成物、その製造方法及び経腸栄養剤
US5326569A (en) * 1992-12-23 1994-07-05 Abbott Laboratories Medical foods for the nutritional support of child/adult metabolic diseases
CA2143420C (en) * 1992-12-23 1999-01-19 Phyllis J. B. Acosta Medical foods for the nutritional support of infant/toddler metabolic diseases
JP4059532B2 (ja) * 1994-08-15 2008-03-12 森永乳業株式会社 腸内細菌の体内移行を阻止するペプチド混合物と、このペプチド混合物を含有する組成物
US5719133A (en) * 1994-09-21 1998-02-17 Novartis Nutrition Ag Adolescent dietary composition
JP4011638B2 (ja) * 1994-12-27 2007-11-21 イーエヌ大塚製薬株式会社 経口経腸栄養組成物
US5569680A (en) * 1995-02-13 1996-10-29 Trustees Of The Univ. Of Penna Method of treating inflammatory bowel disease with tributyrin
DE19528461A1 (de) * 1995-08-03 1997-02-06 Braun Melsungen Ag Präparat zur Ernährung
JPH09323979A (ja) * 1996-06-04 1997-12-16 Meiji Milk Prod Co Ltd 核酸を用いた免疫調節組成物
GB9701674D0 (en) * 1997-01-28 1997-03-19 Novartis Nutrition Ag Use of organic compounds
US6124486A (en) * 1997-01-31 2000-09-26 Eastman Chemical Company Process for making low calorie triglycerides having long and short fatty acid chains
WO1998041216A1 (en) * 1997-03-17 1998-09-24 Tam Yun K Composition for prevention of hepatic steatosis
GB9709082D0 (en) * 1997-05-06 1997-06-25 Ciba Geigy Ag Organic compositions
US5922766A (en) * 1997-07-02 1999-07-13 Acosta; Phyllis J. B. Palatable elemental medical food
EP0891719A1 (en) * 1997-07-14 1999-01-20 N.V. Nutricia Nutritional composition containing methionine
AU2186699A (en) * 1998-02-09 1999-08-23 Meiji Milk Products Co., Ltd. Preventives and remedies for intestinal mucosal disorder
US6369252B1 (en) * 1998-02-26 2002-04-09 The University Of Georgia Research Foundation, Inc. Structured lipids
NZ510342A (en) * 1998-09-11 2003-07-25 Danisco Cultor America Inc Reduced calorie plastic fat composition
JP2000119180A (ja) * 1998-10-06 2000-04-25 Nisshin Flour Milling Co Ltd 経腸栄養剤
US7115297B2 (en) * 2000-02-22 2006-10-03 Suzanne Jaffe Stillman Nutritionally fortified liquid composition with added value delivery systems/elements/additives

Also Published As

Publication number Publication date
CZ300129B6 (cs) 2009-02-18
MXPA03004348A (es) 2003-08-19
PL202031B1 (pl) 2009-05-29
CN1477950A (zh) 2004-02-25
NO20032160L (no) 2003-07-14
EE200300198A (et) 2003-08-15
CZ20031337A3 (cs) 2003-09-17
DK1337236T3 (da) 2004-12-13
PL361634A1 (en) 2004-10-04
DE10057290B4 (de) 2004-01-08
PT1337236E (pt) 2004-11-30
BR0115451A (pt) 2004-01-06
SK5612003A3 (en) 2003-10-07
RU2295952C2 (ru) 2007-03-27
US7947303B2 (en) 2011-05-24
KR100861889B1 (ko) 2008-10-09
HU228351B1 (hu) 2013-03-28
DE50103152D1 (de) 2004-09-09
CA2429270A1 (en) 2002-05-23
IL155840A0 (en) 2003-12-23
CA2429270C (en) 2009-08-18
KR20030069172A (ko) 2003-08-25
ZA200303722B (en) 2004-04-16
JP2004513912A (ja) 2004-05-13
EP1337236A1 (de) 2003-08-27
US20040097404A1 (en) 2004-05-20
WO2002039978A1 (de) 2002-05-23
DE10057290A1 (de) 2002-06-06
BRPI0115451B1 (pt) 2016-07-19
SI1337236T1 (en) 2004-12-31
EP1337236B1 (de) 2004-08-04
ES2223015T3 (es) 2005-02-16
IL155840A (en) 2008-11-03
HRP20030395A2 (en) 2005-04-30
SK286199B6 (sk) 2008-05-06
AU2002224848B2 (en) 2006-06-15
ATE272390T1 (de) 2004-08-15
HUP0301386A2 (hu) 2003-09-29
IS6815A (is) 2003-05-14
NO20032160D0 (no) 2003-05-13
WO2002039978A8 (de) 2002-07-18
AU2484802A (en) 2002-05-27
NZ525812A (en) 2004-03-26
KR20080069280A (ko) 2008-07-25
EE05209B1 (et) 2009-10-15
HUP0301386A3 (en) 2008-04-28
NO333003B1 (no) 2013-02-11
HRP20030395B1 (hr) 2011-10-31

Similar Documents

Publication Publication Date Title
IS2377B (is) Fæðubótarefni til inngjafar í garnir sem næring utan meltingarvegar eða næring að hluta til um garnir/munn fyrir alvarlega veika sjúklinga, langveikasjúklinga og vannært fólk
IL139681A0 (en) Pharmaceutical compositions containing vitamin b6
AU2002224848A1 (en) Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of the critically ill, the chronically ill and people with malnutrition
US20100152107A1 (en) Long-term feed - cancer patient
TR200100610T2 (tr) Asetil L-karnitin ve alfa-lipoik asit içeren antioksidant bileşim
KR920000324A (ko) 필수 지방산 처리법
BR9709838A (pt) Regime de administração que fornece um perfil de plasma no sangue de um inibidor de h+,k+-atpase composição farmacêutica oral uso da mesma e de inibidor h+,k+-atpase e processos para melhorar a inibição de secreção de ácido gástrico e o efeito terapêutico no tratamento de perturbações gastrintestinais e para receber um perfil estendido de plasma de um inibidor de h+,k+-atpase
MX9205722A (es) Composicion alimenticia enteral contra el cancer
JP2002523456A (ja) アスコルビン酸塩−イソケルセチン組成物
ATE365743T1 (de) Immunverstärkende verbindungen
IS5416A (is) Samsetning til að bæla fráhvarfseinkenni og fíkn í áfengi hjá áfengissjúklingum og fyrirbyggja misnotkun áfengis hjá heilbrigðum einstaklingum
CA2462580A1 (en) Utilization of phosphatidylserine in the treatment of attention deficit syndrome (adhs)
JP5118863B2 (ja) 催眠用医薬組成物
EP2716167A1 (en) Non-pharmaceutical composition comprising short chain fatty acids
BR112012009380A2 (pt) intestino e a recuperação muscular
CA2408528A1 (en) Creatine salt having enhanced nutritional and therapeutic efficacy and compositions containing same
CA2551043A1 (en) The use of cystine or cysteine for the prevention and treatment of oxidative stress caused by haemodialysis and of acute or chronic kidney diseases
AU6725300A (en) Non-hygroscopic salts of active ingredients having therapeutical and/or nutritional activities and orally administrable compositions containing same
Datzmann et al. Vitamin and trace element administration during continuous renal replacement therapy (CRRT) in the Intensive Care Unit (ICU)
ES2375391A1 (es) Composición de complemento nutricional.
Dumas et al. P. 17 Enteral administration of ornithine α-ketoglutarate after small bowel resection in rats: changes in intestinal mucosa
Andersson et al. P. 16 Determination of proteasome activity in human muscle and liver tissue
RU2002101613A (ru) Способ коррекции иммуно-и гепатотоксических эффектов циклофосфана